Zacks Investment Research on MSN
PacBio Enters Carrier Screening Market With PureTarget Expansion
PacBio PACB announced last week its entry into the high-throughput carrier screening market with an expanded PureTarget portfolio powered by its HiFi sequencing technology. The new offering replaces ...
David Godler is the group leader of the diagnosis and development laboratory at the Murdoch Children’s Research Institute ...
The maturation of proteomics as a separate experimental field from genomics has highlighted the importance of obtaining information concerning a given protein’s activation state. This information can ...
Fragment-based drug design (FBDD) has led to a revolution in contemporary drug discovery, facilitating a bottom-up approach to the identification and evolution of bioactive small molecules into viable ...
Luciferase-based reporter cell lines are invaluable for detecting cellular responses to signaling pathways in vitro, enabling high-throughput screening and profiling of inhibitors or activators. In ...
PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced its entry into the high-throughput carrier screening market with a significantly ...
Metrion Biosciences ("Metrion"), the specialist preclinical contract research organization (CRO) and a global leader in ion channel services, today announced the launch of its validated, ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...
PacBio (PACB) announced its entry into the high-throughput carrier screening market with a significantly expanded and enhanced suite of PureTarget products. The updated solutions leverage PacBio’s ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results